• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Nanomaterials-mediated lysosomal regulation:a robust protein-clearance approach for the treatment of Alzheimer's disease

摘要Alzheimer's disease is a debilitating,progressive neurodegenerative disorder characterized by the progressive accumulation of abnormal proteins,including amyloid plaques and intracellular tau tangles,primarily within the brain.Lysosomes,crucial intracellular organelles responsible for protein degradation,play a key role in maintaining cellular homeostasis.Some studies have suggested a link between the dysregulation of the lysosomal system and pathogenesis of neurodegenerative diseases,including Alzheimer's disease.Restoring the normal physiological function of lysosomes hold the potential to reduce the pathological burden and improve the symptoms of Alzheimer's disease.Currently,the efficacy of drugs in treating Alzheimer's disease is limited,with major challenges in drug delivery efficiency and targeting.Recently,nanomaterials have gained widespread use in Alzheimer's disease drug research owing to their favorable physical and chemical properties.This review aims to provide a comprehensive overview of recent advances in using nanomaterials(polymeric nanomaterials,nanoemulsions,and carbon-based nanomaterials)to enhance lysosomal function in treating Alzheimer's disease.This review also explores new concepts and potential therapeutic strategies for Alzheimer's disease through the integration of nanomaterials and modulation of lysosomal function.In conclusion,this review emphasizes the potential of nanomaterials in modulating lysosomal function to improve the pathological features of Alzheimer's disease.The application of nanotechnology to the development of Alzheimer's disease drugs brings new ideas and approaches for future treatment of this disease.

更多
广告
作者 Mengqi Hao [1] Jianjian Chu [2] Tinglin Zhang [3] Tong Yin [2] Yuankai Gu [2] Wendanqi Liang [1] Wenbo Ji [2] Jianhua Zhuang [2] Yan Liu [4] Jie Gao [3] You Yin [5] 学术成果认领
作者单位 Department of Neurology,Second Affiliated Hospital of Naval Medical University(Shanghai Changzheng Hospital),Shanghai,China;School of Health Science and Engineering,University of Shanghai for Science and Technology,Shanghai,China [1] Department of Neurology,Second Affiliated Hospital of Naval Medical University(Shanghai Changzheng Hospital),Shanghai,China [2] Changhai Clinical Research Unit,Shanghai Changhai Hospital,Naval Medical University,Shanghai,China [3] Department of Clinical Pharmacy,Xinhua Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China [4] Department of Neurology,Second Affiliated Hospital of Naval Medical University(Shanghai Changzheng Hospital),Shanghai,China;Department of Neurology,Shanghai East Hospital,School of Medicine,Tongji University,Shanghai,China [5]
栏目名称 Reviews
DOI 10.4103/NRR.NRR-D-23-01736
发布时间 2024-12-24
提交
  • 浏览0
  • 下载0
中国神经再生研究(英文版)

中国神经再生研究(英文版)

2025年20卷2期

424-439页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷